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Abstract
Little is known about the role of activin B during folliculogenesis. This study investigated the expression levels of activin/inhibin subunits
(bA, bB, and a), steroid enzyme, and gonadotrophin receptors in theca (TC) and granulosa cells (GC) by QPCR and activin A and B and
inhibin A protein levels in follicular ﬂuid (FF) of developing sheep follicles during estrus and anestrus. The effect of activin B on androgen
production from primary TC cultures in vitro was also assessed. During folliculogenesis, in anestrus and estrus, FF activin B
concentrations and thecal and GC activin bB mRNA levels decreased as follicle diameter increased from 1–3 to O6 mm regardless of
estrogenic status. Estrogenic preovulatory follicles had reduced concentrations of FF activins B and A, and TC and GCs expressed higher
levels of activin bA mRNA at 3–4 mm, and TCs more inhibin a mRNA at O4 mm stages of development compared with nonestrogenic
follicles. Activin B decreased androstenedione production from primary TCs in vitro, an effect blocked by inhibin A. Thus, sheep follicles
1–3 mm in diameter contained high FF levels of activin B, which decreased as the follicle size increased, and, like activin A, suppressed
thecal androgen production in vitro, an effect blocked by inhibin. Furthermore, the theca of large estrogenic follicles expressed high
levels of inhibin a and activin bA mRNA suggesting local thecal derived inhibin A production. This would inhibit the negative effects of
thecal activins B and A ensuring maximum androgen production for enhanced estradiol production by the preovulatory follicle(s).
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Introduction
Activin and inhibin are members of the TGFb super-
family that consists of over 40 ligands including the bone
morphogenetic proteins (BMPs), myostatin, and growth
and differentiation factors (GDFs; Knight & Glister 2006).
Activin and inhibin were originally identiﬁed from
ovarian follicular ﬂuid (FF) and have since been
implicated in many ovarian processes necessary for
normal and successful follicle development.
Structurally, activins are disulﬁde-linked dimers,
where activin A and activin B are homodimers of activin
bAa n dbB subunits respectively. Inhibin is composed of
ana subunit heterodimerizedwith eithera bA(inhibin A)
or a bB (inhibin B) subunit (Knight et al. 2011). Activins
signal through the SMAD2/3 pathway byinteracting with
one of the two activin type II receptors (ACVR2A
(actRIIA) or ACVR2B (actRIIB)), which heterodimerize
with the type I activin receptor ACVR1B (actRIB). The
activin type IB receptor (also known as ACVR1B (ALK4))
is commonly regarded as the receptor that activins use,
but activins B and activin AB (bA/bB heterodimer) might
alsosignalthroughthetypeICactivinreceptors(ACVR1C
(ALK7)) (Bernard et al. 2006). The type I receptor initiates
a signaling cascade by activating a phosphorylation
cascade through SMAD2/3 that complexes with SMAD4
and translocates to the cell nucleus to modulate gene
transcription. The effects of activin are antagonized by
inhibin, which acts by blocking activin binding to its
receptors and by follistatin, which forms complexes with
activin extracellularly preventing activin availability
(Knight et al. 2011).
Inhibins and activins are made by cells of the
developing follicle and accumulate in high concen-
trations in the antral FF. Previous studies have shown that
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inhibin, which acts in a feedback mechanism to the
pituitary to modulate gonadotrophin production
(Padmanabhan & McNeilly 2001, McNeilly et al.
2003). Mouse models were used to investigate the
importance of activin in development and fertility. Mice
lacking the activin bA subunit are neonatal lethal
(Matzuk et al. 1995) while activin bB null mice survived
to adulthood (Vassalli et al. 1994). Activin B-deﬁcient
male mice exhibited normal fertility; however, females
displayed profound inability to reproduce and their
offspring are perinatal lethal. A GC-speciﬁc conditional
activin bA knockout mouse was created and was sub-
fertile (Pangas et al. 2007), and the same observation was
found when mature bA was replaced with mature bB
(Brown et al. 2000). These ﬁndings suggest that both
activins A and B are important for regulating ovarian
function and that activin B is necessary for female
fertility. However, limited research has been carried out
to determine the presence and function of activin B in
somatic follicular cells due to a lack of speciﬁc assays for
measuring activin B. While it was thought that activin B
functions simply as an alternative to activin A, at least in
thecal cells (TCs) from cattle activin B appears to have no
activity while activin A will suppress androgen pro-
duction (Knight et al. 2011). In sheep while the activin
bB subunit mRNA and protein is expressed in both the
testis and the ovary, no inhibin B is produced, and
inhibin A is the only form produced and secreted by the
testes and ovaries (McNeilly et al. 2002). These ﬁndings
are interesting given that activin B is present during
follicle development, and inhibin B functions during
the follicular phase in human folliculogenesis but
does not appear to be necessary for sheep fertility
(McNeilly et al. 2002).
We have now used a new speciﬁc ELISA for activin B
(Ludlow et al. 2009) to investigate the role of activin B in
folliculogenesis. Using sheep, we determined the
potential role of activin B in modulating thecal androgen
production in vitro and the pattern of production of
activin B in vivo when follicular development continues
in the face of low LH pulse frequencies in anestrus
(McNeilly et al. 1982), when LH pulse frequency is
highest in the late follicular phase of the normal cycle
(Wallace et al. 1988), and after an induced preovulatory
LH surge at a time when estradiol (E2) and androgen
production is suppressed before ovulation (Baird et al.
1981). In these studies, the concentration of FF E2 was
also measured and used to determine follicle dominance
to compare levels of gene expression and protein
accumulation in follicles in different states of health.
Previous studies haveshownthat in follicles O2.5 mm in
diameter, the size beyond which follicles are gonado-
trophin dependent in sheep (McNeilly et al. 1986, 1987,
McNeilly & Fraser 1987), FF levels of E2 directly reﬂect
the state of health or atresia of follicles (Carson et al.
1981). High levels of E2 reﬂect healthy preovulatory
follicles expressing high levels of LH receptors in both
GCs and TCs (Webb & England 1982), and this is
correlated with high output of E2 when the individual
follicles are incubated in vitro (Webb & England 1982,
McNeilly & Fraser 1987, McNeilly et al. 1987). In
contrast, low levels of E2 both in FFand in in vitro culture
are associated with follicles in varying states of atresia
producing high levels of androgens (Carson et al. 1981,
Webb & England 1982).
The objectives of this study were to measure the
concentrations of activin B in FFand compare with those
for activin A, inhibin A, and the estrogenic status of each
individual follicle and correlate these measurements
with the expression patterns of activin subunits (bA, bB),
inhibin a, gonadotrophin receptors, and components of
the steroidogenic pathway in TCs and GCs.
Results
Changes in activin B during folliculogenesis
The mean concentrations of activin B, A, and inhibin A,
in the FF of follicles collected from sheep during
anestrus, and the follicular phase (preovulatory and
post-LH surge) are shown in Fig. 1. The concentrations of
E2 were measured in the antral ﬂuid of each follicle to
allow segregation of follicles based on estrogenic status
and are graphed into high and low estrogenic groups
reﬂecting the dominant or subordinate status of each
follicle respectively.
The results showed that levels of E2 were signiﬁcantly
lower in the antral ﬂuid of follicles during anestrus
compared with follicles during the follicular phase of the
estrous cycle (P!0.05) (data not shown). There was also
a signiﬁcant decrease in the concentration of E2
following the LH surge in follicles 1–3, 3–4, and
O6 mm in diameter (P!0.001). The greatest concen-
tration of E2 was found in preovulatory follicles O6m m
in size (9449G1700 ng/ml).
Antral activin B concentration decreased as follicle size
increased
Measurements showed that activin B concentration
decreased (P!0.001) as follicle size increased during
the three reproductive phases tested regardless of the
estrogenic content of follicles (Fig. 1). At the small
antral stage (1–3 mm in diameter), the average activin B
concentration was 877G47 ng/ml, from 3–4 mm was
359G18 ng/ml, 173G17 ng/ml from 4–6 mm, and at
O6 mm follicular activin B concentrations decreased to
72G6 ng/ml.
Signiﬁcant differences were observed between the
levels of activin B and the phase of the reproductive
cycle within each follicle size group assessed. Small
follicles (1–3 mm) from ovaries of sheep during anestrus
had signiﬁcantly less antral activin B than follicles during
the follicular phase of the estrous cycle (P!0.01).
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surge by w30% from those concentrations observed in
follicles just before the LH surge (P!0.05). In follicles
measuring 3–4 and 4–6 mm in diameter, activin B levels
were signiﬁcantly lower during anestrus (P!0.001), but
no signiﬁcant differences were found between stages of
the follicular phase (prior and post-LH surge). No
differences in FF activin B concentrations were observed
between cycling and anestrus follicles O6m m i n
diameter, nor were any differences found preceding
and following the preovulatory LH surge in follicles of
this size.
When follicles were segregated based on the estro-
genic status, the results showed that levels of FFactivin B
in estrogenic (high E2) preovulatory follicles (O6 mm)
during the follicular phase were lower than non-
estrogenic (low E2) follicles, measuring 71G9 and 106
G14 ng/ml respectively (P!0.05; Fig. 1B). The concen-
tration was also reduced after the LH surge in follicles
O6 mm in diameter (Fig. 1C). During the anestrus phase,
estrogenic follicles 3–4 mm in diameter had lower FF
activin B levels than nonestrogenic follicles of the
same size (P!0.001; Fig. 1A). No other differences
between estrogenic and nonestrogenic follicle activin B
concentrations were observed.
Activin A and inhibin A levels follow a similar pattern
The levels of activin A and inhibin A were measured
from the same follicles used to map activin B
concentrations. Data for all phases were averaged within
size groups, and results showed that the concentration
of activin A increased from 474G34 ng/ml in small
antral follicles (1–3 mm) to 822G104 ng/ml in 3–4 mm,
1338G160 ng/ml in large antral follicles (4–6 mm), after
which the levels of activin A in the FF decreased to
734G54 ng/ml (P!0.001) as follicles approached
preovulatory size (O6m m ) .
The concentration of antral inhibin A followed a
similar pattern to that of activin A. The average
concentration of FF inhibin in follicles, regardless of
cyclic stage, increased from 526G37 ng/ml in 1–3 mm
follicles to 849G86 ng/ml in 3–4 mm, 827G110 ng/ml
in 4–6 mm, and then signiﬁcantly decreased to 591
G40 ng/ml in follicles O6 mm in diameter (P!0.05).
Moreover, differences were found between inhibin A
concentrations in 1–3 mm follicles during the three
phases of the cycle assessed. The concentration of
inhibin A was signiﬁcantly higher (P!0.001) measuring
830G99 ng/ml after the LH surge and only 476G45 and
366G52 ng/ml before the LH surge and during anestrus
respectively.
Estrogenic follicles O6 mm in diameter had 602
G56 ng/ml and nonestrogenic follicles had 990
G130 ng/ml FF activin A (P!0.01), and a reduced
level of FF activin A was also found after the LH surge in
estrogenic follicles O6 mm in diameter (P!0.05).
However, no other differences in activin A concentration
were found between estrogenic and nonestrogenic
follicles at other stages of development (Fig. 1).
No signiﬁcant differences in FF inhibin A content were
found between the estrogenic and nonestrogenic
follicles during the follicular phase of the estrous cycle
(Fig. 1B). However, higher levels of FF inhibin were
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Figure 1 Follicular ﬂuid concentrations of activin
A, B, and inhibin A (ng/ml) during (A) anestrus
(nZ10 sheep), (B) preovulatory (nZ10 sheep),
and (C) after the LH surge (nZ10 sheep) in
follicles 1–3 to O6 mm in diameter. Data shown
are the average GS.E.M. concentration (ng/ml) for
all follicles in each size group. Signiﬁcance was
calculated between estrogenic (white bars) and
nonestrogenic (black bars) groups using Student’s
t-test (*P!0.05, **P!0.01, and ***P!0.001,
****P!0.0001). Signiﬁcance of differences
between groups is also indicated above the graphs
and is calculatedon the average for eachsize class
regardless of the follicular estrogenic status.
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1–3 mm in diameter (P!0.05) and during anestrus in
estrogenic follicles 1–3 and 3–4 mm in diameter
(P!0.01).
Activin bB subunit expression during the reproductive
cycle
The follicles collected during anestrus, before and
following the LH surge during the follicular phase of
the estrous cycle, were divided into estrogenic and
nonestrogenic based on the FF E2 concentrations.
The ﬁve follicles with the highest and ﬁve with the
lowest levels of FF E2 within each size group (1–3, 3–4,
4–6, and O6 mm diameter) for each phase of the cycle
(anestrus, preovulatory, and after the LH surge) were
then selected for gene expression studies. Follicles were
collected from nR3 sheep for each group analyzed.
Each follicle was treated separately, and no pooling
of mRNA or FF from individual follicles was carried
out within this study.
The expression levels of mRNA encoding activin bA,
bB, and inhibin a subunits were measured in TC and GC,
and estrogenic follicles were found to have differential
expression levels at speciﬁc stages of development.
During anestrus (Fig. 2), estrogenic follicles 1–3 mm in
diameter expressed more mRNA encoding bA, bB, and a
in TCs (P!0.05) and more a in GCs (P!0.001). Follicles
from 3 to 4 mm in diameter produced more bA in TCs
and more a and bA in GCs (P!0.05). Follicles O4m m
in diameter were not found to have any differential
levels between estrogenic and nonestrogenic follicles.
There was a signiﬁcant difference between the levels
of bA mRNA expressed between thecal cells in those
follicles from 1 to 3 mm in diameter compared with
follicles of 4–6 mm in diameter (P!0.05).
During the preovulatory phase of estrus (Fig. 3), TC
and GCs from 3 to 4 mm estrogenic follicles produced
higher levels of bA mRNA than nonestrogenic follicles.
TCs from follicles 4–6 and O6 mm in diameter produced
higher levels of a subunit (P!0.05), and TCs from
follicles O6 m ma l s op r o d u c e dm o r ebAm R N A
(P!0.01). No differences were observed in GC
expression between estrogenic and nonestrogenic
follicles in follicles O4 mm in diameter during the
preovulatory phase. Signiﬁcant differences were found
between expression levels of the a subunit in TCs of
follicles 1–3 mm compared with follicles O6m m
in diameter (P!0.05) and between follicles 3–4 and
O6m m( P!0.05).
AftertheLHsurge(Fig.4),TCsfromestrogenicfollicles
1–3 mm in diameter produced higher levels of mRNA
encoding bA, bB, and a subunits (P!0.05), and GCs
producedmoreamRNA(P!0.001).TCsfromestrogenic
follicles 4–6 mm in diameter had reduced levels of bA
subunit expression (P!0.01). Signiﬁcant differences
were found between expression levels of bA subunit in
TCs of follicles from size categories: 1–3 mm com-
pared with 4–6 mm (P!0.01), 3–4 mm compared with
4–6 mm (P!0.01), and 4–6 mm compared with O6m m
(P!0.01) follicles. Differences were also observed
for bB expression: 1–3 mm compared with 4–6 mm
(P!0.001) and 4–6 mm compared with O6m m
(P!0.01).
In our study, low levels of inhibin a protein were
present in the thecal layer with high levels present in
GCs of preovulatory estrogenic follicles (Fig. 5C) ident-
iﬁed by the expression of aromatase (Fig.5A). In contrast,
expression in the theca layer and GCs was either absent
or at a low level in aromatase-negative follicles (Fig. 5C
and D). Activin bA subunit was expressed in GCs and in
the theca layer of both aromatase-positive and -negative
follicles (Fig. 5E and F). Future studies will be required to
determine the exact cell types that are expressing both
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Figure 2 Follicles collected during anestrus. Gene expression levels for
activin and inhibin subunits bA, bB, and alpha (a) in theca and
granulosa (GC) cells of follicles (1–3 to O6 mm in diameter). Follicles
were segregated based on FF estrogenic content (high (white bars) and
low (black bars) estrogen) (*P!0.05, **P!0.01, and ***P!0.001).
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contributing to the inhibin that controls androgen
production.
Expression levels in components of steroidogenic
pathway
During anestrus (Fig. 6), TCs from estrogenic follicles
1–3 to 4 mm in size produced less mRNA encoding StAR
and more mRNA encoding CYP17A1 (CYP17)a n d
3bHSD (P!0.05). Estrogenic follicles 3–4 mm in size
produced higher levels of CYP19A1 (CYP19) mRNA in
GCs during anestrus (P!0.05), and higher expression of
FSHR and 3bHSD was found in GCs of estrogenic
follicles 3–4 mm in diameter (P!0.05). Signiﬁcant
differences between expression levels of different follicle
sizes are shown on the graphs in Fig. 6.
TCs from preovulatory follicles (Fig. 7) of 3–4 mm in
diameter expressed more mRNA encoding 3bHSD
(P!0.05), and follicles O6 mm were found to have
more StAR (P!0.01) and CYP17A1 (P!0.05) mRNA.
No differences were found between estrogenic and
nonestrogenic follicles during the preovulatory phase in
levels of mRNA encoding LHR, FSHR, CYP19A1,a n d
3bHSD. Differences between the expression levels and
size groups are displayed on the graphs in Fig. 7
(calculated grouped into sizes regardless of estrogenic
status).
After the LH surge (Fig. 8), TCs from estrogenic
follicles 4–6 mm in diameter contained more StAR and
3bHSD mRNA (P!0.05) and O6m m e s t r o g e n i c
follicles had lower levels of mRNA encoding StAR and
LHR (P!0.05). GCs from estrogenic follicles 1–3 mm in
diameter expressed more CYP19A1 and 4–6 mm
expressed less 3bHSD mRNA (P!0.05). Signiﬁcant
differences between expression levels of each follicle
size group, regardless of estrogenic status, were
calculated and are shown on the graphs in Fig. 8.
Activin B suppresses androstenedione production
Sheep TCs cultured in vitro in the presence of 1 ng/ml
activin B produced 85% less androstenedione than
control cells (Fig. 9). At concentrations of 10 and 100 ng/
ml, activin B reduced androstenedione production by 93
and 99% compared with control levels (P!0.001). The
effects of activin B were similar to levels observed for
activin A-treated cells, which were also signiﬁcantly
suppressed in the presence of activin A (83% less than
control levels at 1 ng/ml, P!0.001).
Inhibin A treatment at 1 ng/ml increased androstene-
dione production by 88% compared with the control
level (P!0.001) and was also able to block the
suppressive effects of activin B (79% increase) and
activin A (70% increase) (P!0.01) at 100 ng/ml. The
effects of activin and inhibin treatment did not alter cell
viability as determined by neutral red assays (data not
shown).
Discussion
This study provides novel information on the expression
patterns and concentration proﬁle of activin B in antral
ﬂuid of individual sheep follicles during follicular
development in anestrus and during the follicular
phase of the estrous cycle before and after the
preovulatory LH surge when follicles are exposed to
radically different patterns of pulsatile LH secretion.
Historically, activin B was thought to function similarly
to activin A, albeit with less potency suggesting perhaps
the use of different receptors for activin B (Corrigan et al.
1991, Mathews & Vale 1991, Nakamura et al. 1992).
This study shows that the expression patterns of activin
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Figure 3 Follicles collected during the preovulatory phase. Gene
expression levels for activin and inhibin subunits bA, bB, and alpha (a)
in theca and granulosa (GC) cells of follicles (1–3 to O6m mi n
diameter). Follicles were segregated based on FF estrogenic content
(high (white bars) and low (black bars) estrogen) (*P!0.05, **P!0.01,
and ***P!0.001).
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The patterns of activins A and Bprotein concentrationsin
FF are disparate, indicating a potentially independent
role for activin B during folliculogenesis. The results of
this study show that activin B suppresses in vitro thecal
androgen production to a similar level as activin A and
that the effects of both activins A and B are blocked by
inhibin A.
The concentration of FF activin B protein was highest
at early antral stages of development and decreased as
follicle size increased. From the primary stage of
folliculogenesis, there is evidence that sheep GCs can
synthesize activin bB subunit as well as inhibin and
follistatin, and from the small antral stage, activin bAi s
found (McNatty et al. 2007). This study shows that
activin bB mRNA is produced in TCs and GCs in varied
quantities throughout antral follicle development.
The abundance of mRNA transcripts encoding activin/
inhibin subunits (bA, bB, and a) and steroidogenic
pathway components (LHR, FSHR, 3bHSD, StAR,
CYP17A1,a n dCYP19A1) were quantiﬁed in GC
and/or TCs isolated from follicles ranging in diameter
from 1–3 (small antral) to O6 mm (preovulatory).
Follicles of these sizes were assessed due to the presence
of antral ﬂuid because these follicles contained sufﬁcient
GCs and TCs for individual follicle expression analyses
and because this size range covers several important
developmental stages. During these stages of develop-
ment, follicles undergo the transition from gonadotro-
phin independence to becoming dependent (McNeilly
et al. 1986), are selected for dominance, acquire LH
receptors and necessary steroidogenic pathway com-
ponents, produce higher levels of androgens and E2,
and become dominant (estrogenic) in preparation for
ovulation (Scaramuzzi et al. 1993, 2011, McNatty et al.
2007). The mechanism by which follicle dominance
occurs in sheep is not well described (McNeilly et al.
1991, Scaramuzzi et al. 1993, 2011). Nevertheless,
those follicles on a dominant growth track do have
signiﬁcantly higher levels of antral ﬂuid E2 than those
destined for atresia (Carson et al. 1981, Webb & England
1982). Therefore, in this study, antral E2 concentrations
were measured and follicles segregated into dominant
and subordinate follicle populations. While there is
insufﬁcient pulsatile LH support for high-level steroid
production to occur during anestrus, follicles remain
in a continuous cycle of growth and regression without
actually reaching the point of ovulation. This study
shows that there are differences in antral activin B
and inhibin A protein concentrations between small
(!4 mm) dominant follicles during anestrus, at a stage of
development where follicle growth would normally be
transitioning into gonadotrophin dependence during
estrus. However, as follicles continue to grow in the
gonadotrophin-dependent phase, the differences in
activin and inhibin levels between dominant and
subordinate follicles are lost. Aromatase expression in
GCs from these follicles is also deﬁcient, and no
differences were found between estrogenic and non-
estrogenic follicles in any genes assessed once follicles
reached 4 mm in diameter. These results suggest that
induction of aromatase and other steroidogenic enzymes
in both TCs and GCs, even in large healthy estrogenic
follicles, is dependent on the frequency of LH pulses
that is limited in anestrus. This is supported by previous
studies that showed that normal follicle steroid
production is induced when LH pulses alone are
replaced during anestrus (McNeilly et al. 1982, Wallace
et al. 1986).
During the follicular phase of the estrous cycle,
decreased concentrations of activins B and A
were found in antral ﬂuid from large dominant
preovulatory follicles in comparison with subordinate
size-matched follicles. At the preovulatory stage of
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Figure 4 Follicles collected after the LH surge of estrus. Gene
expression levels for activin and inhibin subunits bA, bB, and alpha (a)
in theca and granulosa (GC) cells of follicles (1–3 to O6m mi n
diameter). Follicles were segregated based on FF estrogenic content
(high (white bars) and low (black bars) estrogen).
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tities as precursors for E2 synthesis in neighboring GCs
(Young & McNeilly 2010). This study conﬁrms previous
reports that activin A reduces androgen production
(Hillier et al. 1991) and shows that activin B suppresses
androgen production from TCs cultured in vitro,a n di t
is not unexpected that follicles producing higher levels
of antral E2 also have lower levels of activins. At this
preovulatory stage, inhibin is produced as an important
feedback mechanism signaling to the pituitary gland to
modulate FSH secretion. A signiﬁcant increase in inhibin
A levels was observed in antral ﬂuid of estrogenic
follicles 1–3 mm in diameter after the ovulatory LH
surge. In sheep, only inhibin A is produced (McNeilly
et al. 2002), and thus, the increased expression of inhibin
a in both the TCs and the GCs of larger follicles that was
observed would result in de novo synthesis of inhibin a
subunit and heterodimerization with activin bAt o
produce inhibin A rather than forming homodimers of
bA. In this instance, inhibin A would function to reduce
activin A production and also to increase androgen
production by blocking the suppressive effects of
residual activins A and B. It is possible that contami-
nation of the TC preparations by GCs was responsible
for the apparent expression of inhibin a in the TCs.
In previous unpublished studies, we have shown
minimal or absent expression of FSHR in the TCs
prepared in exactly the same way as in this study, but
we did not do this in this study. However, given the large
difference in the threshold cycle (CT) values for the
QPCRs, in that the levels of inhibin a subunit mRNA
were between three- and six-fold higher in the TCs than
the GCs for the same follicle, this would suggest that the
TC preparations would be contaminated with between
three- and six-fold more GCs than TCs. This is not
conceivable, but in future studies, FSHR mRNA levels
will need to be examined as complete evidence of the
minimal or absent contamination of the TC preparations.
In our study, low levels of inhibin a protein were present
in the thecal layer as well as GCs of preovulatory
estrogenic follicles. Future studies will be required to
determine the exact cell types that are expressing each
GC
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Figure 5 Immunohistochemistry for aromatase (A
and B), inhibin a (C and D), and activin bA subunit
(E and F) in an aromatase-positive estrogenic (A, C
and E) and aromatase-negative nonestrogenic (B,
D and F) large follicles in an ovary taken in the
follicular phase of the estrous cycle 36 h after
prostaglandin injection. Th, thecal layer; GC,
granulosa cells.
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inhibin that controls androgen production.
As follicles developed from small antral to large
preovulatory follicles, dynamic switches in activin and
inhibin subunit gene expression occurred. Several
studies have previously looked at expression of bA, bB,
andasubunitsinfolliclesofhumanovaries,andalthough
not in complete agreement, the evidence indicates that
various degrees of expression for all three subunits were
found in GCs and TCs (Yamoto et al. 1992, 1993, Roberts
et al. 1993, Jaatinen et al. 1994, Roberts & Barth 1994).
In adult monkey ovaries, the bB subunit was observed in
small antral follicles before a or bA mRNA was detected
(Schwall et al. 1990). Activin bA and bB subunit mRNA
was detected in GCs and TCs from small porcine antral
follicles (van den Hurk & Van de Pavert 2001). In sheep
ovaries,noinhibinahadpreviouslybeendetectedinTCs
butwasdetectedinGCsofsomehealthyantralfolliclesat
allstagesoftheestrouscycle(Tisdalletal.1994).Inantral
follicles expressing bA, the a subunit and follistatin were
also always detected; however, the converse was not
true. In preantral and atretic sheep follicles, no a or bA
wasdetected, butfollistatin waspresent.Activinhasbeen
localized to oocytes and GCs in rodents, pigs, and cows
(Hulshof et al.1 9 9 7 , van den Hurk & Van de Pavert 2001,
Zhao et al.2 0 0 1 ) and in human GCs and TCs (Roberts
et al. 1993). The effects of activin on follicular develop-
ment are controversial where some studies have reported
a stimulatory effect (Thomas et al. 2003, Silva et al.
2006,Telfer etal.20 08 )andothers indicatedaninhibitory
effect (Mizunuma et al.1 9 9 9 , Knight et al. 2011).
Expression levels of activin receptors, betaglycan,
follistatin, intracellular smads, and presence of the
many TGFb signaling antagonists have implications on
efﬁcacy of activin signal transduction (Knight et al. 2011,
Scaramuzzi et al. 2011). For example, expression of the
inhibin receptor betaglycan is higher in TCs than in GCs,
and expression increased as follicle growth progressed
in antral bovine follicles (Glister et al. 2010). Betaglycan
is also in TCs and GCs of human follicles and in rodents
(Drummond et al. 2002, Liu et al. 2003). In sheep,
betaglycan was expressed in the oocytes of primordial
follicles and in GCs and TCs of preantral follicles
(McNatty et al. 2007). The presence of betaglycan in
these cells indicates that TCs and GCs are target cells of
inhibin, as betaglycan functions by mediating functional
antagonism of activin signaling (Lewis et al. 2000).
In cows, the expression of the type I activin receptor
in TCs fell in large estrogenic follicles (Glister et al.
2010), suggesting an additional control mechanism for
reducing activin signaling.
The results of this study suggest that synthesis of activin
and inhibin subunits occurred at speciﬁc developmental
time points throughout folliculogenesis, subsequently
a corresponding amount of protein accumulated in the
antral ﬂuid of growing follicles. Follicles destined for
ovulation synthesized greater levels of mRNA encoding
activin bA in TCs and GCs and inhibin a in TCs and had
lower levels of activins A and B in the FF of O6m m
dominant follicles compared with subordinate follicles.
We found that activins A and B suppressed androgen
production in TCs, and inhibin blocks this suppressive
effect. Therefore, in estrogenic follicles, higher pro-
duction of activin bA and activin A at 3–4 mm in
diameter suggests that androgen synthesis is being kept
in check at this stage by activin A production. Once
follicles reach gonadotrophin dependence and GCs of
the selected preovulatory follicle(s) switch on aromatase
(CYP19A1) expression to produce E2, inhibin a mRNA is
synthesized producing inhibin A that functions to block
the suppressive effects of activin on androgen pro-
duction. The result would increase androgen synthesis,
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Figure 6 Follicles collected during anestrus. Gene expression levels for
StAR, CYP17A1, 3bHSD, and LHR in theca cells and CYP19A1, FSHR,
3bHSD, and LHR in granulosa cells (GC) are graphed. Follicles (1–3 to
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(high (white bars) and low (black bars) estrogen) (*P!0.05, **P!0.01,
and ***P!0.001).
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neighboring GCs. However, it has previously been
assumed that the increase in inhibin production was
entirely produced bythe GCs of theestrogenic follicle.In
our study, it is clear that the TCs produce inhibin andthus
alocal TC-derived inhibin system is activated to enhance
androgen production by blocking local activins A and B
inhibition.
After ovulation, the secretion of E2 and thecal
androgens decreases dramatically (Baird et al. 1981).
In this, the expression of inhibin a and activin bA
subunits in estrogenic follicles is also dramatically
reduced to be equivalent to the level of nonestrogenic
follicles shortly after the LH surge signaling ovulation.
The maintained levels of a inhibin and activin bA
subunits producing inhibin A and the maintained levels
of inhibin A in the FF of these follicles O3 mm diameter
after the preovulatory LH surge is in accordance with the
maintained secretion of inhibin by the ovary after the
preovulatory surge in sheep (McNeilly et al. 1989,
Campbell et al. 1990).
No two follicles are in the same microenvironment of
growth factors, contain the same numbers of GCs and
TCs, or have the same blood supply at any one time
(McNatty et al. 2007). These results show that there are
differences in the levels of activin and inhibin subunit
expression in TCs and GCs of follicles that are destined
for ovulation in comparison to those that regress. In this
study, we have assessed the expression levels of
steroidogenic enzymes and pathway components in
TCs andGCs. In general,all follicles 1–3 mm in diameter
expressed mRNA encoding StAR, CYP17A1, and 3bHSD
in TCs and CYP19A1 in GCs. As follicles progressed
along the developmental pathway, CYP17A1 expression
levels increased dramatically in TCs of 3–4 mm follicles.
This change signiﬁes the point at which androgen
production begins and CYP17A1 is a rate-limiting
enzyme required for this process (Young & McNeilly
2010). As expected, follicles during anestrus displayed
reduced expression patterns of steroidogenic pathway
components in comparison with the preovulatory follicu-
lar phaseprimarilyduetothereducedLHpulsefrequency
in anestrus as normal steroid secretion can be induced
by replacement of LH pulses alone (McNeilly et al.
1982, Wallace et al. 1986, McLeod & McNeilly 1987).
Before the LH surge, TCs of estrogenic follicles
O6 mm in diameter produce more mRNA encoding
CYP17A1 and StAR, and these levels dropped dramati-
cally following the LH surge. This may be due to
downregulation of LH receptors, and we have shown in
this study that the LH surge also caused a reduced level
of LHR expression in TCs of estrogenic follicles O6m m
in diameter compared with subordinate follicles. In GCs
of the same follicles, levels of CYP19A1 expression were
high before the LH surge but then radically reduced
following the LH surge. The fact that estrogenic follicles
require greater amounts of androgen production in order
to produce more E2 supports this data, which showed
higher expression levels of steroidogenic pathway
components in both TCs and GCs before the LH surge.
The reduction in steroid enzyme levels in both the TCs
and GCs explains the dramatic reduction in secretion of
E2 and androgens after the LH surge.
In summary, this is the ﬁrst study showing that FF
activin B protein levels are highest in small antral
follicles and decrease as follicle size increased. Domi-
nant preovulatory follicles had reduced amounts of FF
activin B protein compared with subordinate follicles of
the same size. In addition, the data showed the
expression patterns of activin bB subunit in TCs and
GCs of antral follicles varied according to the estrogenic
status of the follicle as well as the size and stage of the
estrous cycle and anestrus. Furthermore, this study
suggests, for the ﬁrst time, that in sheep follicles, the
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Figure 7 Follicles collected during the preovulatory phase of estrus.
Gene expression levels for StAR, CYP17A1, 3bHSD, and LHR in theca
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graphed. Follicles (1–3 to O6 mm in diameter) were segregated based
on FF estrogenic content (high (white bars) and low (black bars)
estrogen) (*P!0.05, **P!0.01, and ***P!0.001).
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www.reproduction-online.org Reproduction (2012) 143 637–650TCs are able to synthesize all subunits required to
produce activin B, A, and inhibin A in a controlled
manner to autoregulate androgen production at the local
TC level regardless of inhibin production by the GCs
during follicular development.
Materials and Methods
Follicle collection
Ovaries were obtained from Scottish Blackface ewes in
accordance with the UK Home Ofﬁce Guideline and Project
Licence approved by the local University of Edinburgh Ethical
ReviewProcess(ERP)andtheAnimals(ScientiﬁcProcedure)Act
1986. The ovaries from ten sheep were collected during the
anestrusphase(July),andtheestrouscyclesinafurther20sheep
were synchronized by withdrawal of progestogen-impregnated
sponges (60 mg medroxyprogesterone acetate per sponge;
Intervet Laboratories Ltd, Cambridge, UK) in November.
Luteolysis was induced on day 10 of the subsequent cycle
using a synthetic PGF2a analog (PG) (100 mg i.m. Estrumate;
Schering-Plough Animal Health, Welwyn Garden City, UK).
Ovaries were collected 36 h after PG in the late follicular phase
from ten sheep just before the LH surge and ten sheep 20 h after
a preovulatory LH surge induced by the i.v. injection of GNRH
agonist (500 mg Buserelin; Sanoﬁ-Aventis, Guilford, UK;
Crawford et al. 2000) just before ovulation. Follicles containing
an antral cavity were dissected from the ovary and measured
and then hemisected in individual wells. The GCs scraped and
washed out from the theca shell into 1 ml PBS and then
centrifugedtoseparatetheGCsfromtheFF.TheFF/PBSsolution
from each individual follicle was stored at K20 8C for ELISA.
The GCs from each individual follicle were then suspended in
lysis buffer (RNeasy Micro kit, Qiagen) and individual theca
shells placed in200 mlRNAlater (Qiagen)andstoredat K20 8C
for gene expression analyses.
Immunohistochemistry for inhibin a and bA subunit
Sections from archived ovaries from two sheep collected in a
previous study in the late follicular phase (at the same time as in
this study, 36 h after PG) (Gubbay et al. 2006) were used to
determine whether inhibin a and activin bA subunits were
present in the thecal layer of follicles. Follicles were classiﬁed
as either estrogen positive and thus preovulatory or estrogen
negative, on the basis of the presence or absence of P450
aromatase determined by immunohistochemistry.
Sections (5 mm thickness) were dewaxed in xylene and
rehydrated in decreasing concentrations of alcohol (100, 90,
and 75%). After a 5 min wash in water and another in 0.05 M
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Figure 8 Follicles collected after the LH surge during estrus. Gene
expression levels for StAR, CYP17A1, 3bHSD, and LHR in theca cells
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646 J M Young and others
Reproduction (2012) 143 637–650 www.reproduction-online.orgTBS, sections were blocked in 3% H2O2 in methanol for
30 min to inhibit endogenous peroxidase activity. Following
another wash in water (5 min) and TBS (2!5 min), combined
avidin–biotin block was performed according to the manufac-
turer’s instructions (Vector Laboratories, Peterborough, UK).
Nonspeciﬁc background was blocked for 30 min at room
temperature with 10% normal goat serum (Diagnostics Scot-
land, Carluke, UK) diluted 1:5 in TBS containing 5% BSA.
Slides were incubated with primary antibodies diluted in
normal blocking serum at 4 8C overnight in a humidity
chamber. Aromatase was detected using a primary antibody
raised in mouse at 1:50 dilution and activinbA bythe E4 mouse
antibody also diluted to 1:50. Inhibin a primary antibody
(PPG/14/6) was biotinylated and used at 1:100 dilution (source
of antibodies (Ludlow et al. 2009)). Negative controls were
performed by replacing the primary antibody with normal
blocking serum. After washing in TBS (2!5 min) to remove
excess primary antibody slides were incubated with
a biotinylated secondary antibody diluted 1:500 in normal
serum for 30 min. Inhibin a slides did not require a biotinylated
secondary antibody as the primary antibody was biotinylated.
After another wash cycle, all slides were incubated in
streptavidin HRP (Vector Laboratories) diluted 1:1000 in TBS
for 30 min. Bound antibody was visualized using 3,30-
diaminobenzidine tetrahydrochloride (Dako, Ely, Cambridge-
shire, UK). Sections were counterstained with hematoxylin,
dehydrated, mounted, and visualized by light microscopy.
Primary TC culture
Ovaries were obtained from sheep during random stages of the
estrous cycle or in anestrus throughout the year and transferred
to the laboratory in Medium199 containing 20 mmol/l HEPES,
100 kIU/l penicillin, 0.1 ng/ml streptomycin, and 1 mg/l
amphotericin (Fungizone) (all supplied by Sigma–Aldrich).
Small follicles (1–3.5 mm in diameter) were dissected from
ovaries in Dulbecco’s PBS without calcium or magnesium, with
particular attention given to removal of all extraneous stromal
tissues surrounding the thecal layers. Follicles were then
hemisected and washed vigorously using a 1 ml syringe,
ﬂushing repeatedly, to separate GCs from the theca shells as
described previously (Campbell et al. 1998). The thecal shells
were then dispersed in an enzyme mixture containing 10 ml
PBS, 5 g/l collagenase, 1 g/l hyaluronidase, 1 g/l protease,
and 0.001% donor calf serum (vol/vol), for w10 min at 37 8C
with gentle agitation. The reaction was stopped by addition of
2 ml FCS, and cells were then washed by centrifugation at
800 g for 5 min and resuspended in culture media (DMEM-F12
with 100 kIU/l penicillin, 0.1 mg/l streptomycin, 3 mmol/l
L-glutamine, 0.1% BSA (w/vol), 2.5 mg/l transferrin, 4 mg/l
selenium, 10 ng/ml bovine insulin, 0.1 ng/ml ovine LH (code#
AFP 8614B-NHPP-NIDDK supplied by Dr A Parlow, NHPP,
Harbor-UCLA, Torrance, CA, USA) and 10 ng/ml LR3 IGF1).
The cell pellets were then resuspended in culture media
and after a further wash, the number and viability of cells
was estimated using Trypan Blue exclusion. Cell viability was
routinely more than 95%.
Cells were plated in 96-well plates at 75 000 cells in a
total of 200 ml media per well. Activin A (code# 338-AC) and
activin B (code# 659-AB) were obtained from R&D Systems
(Abingdon, Oxon, UK) and inhibin A from NIBSC (code #
91/624, Hertfordshire, UK). Cells were cultured under standard
culture conditions consisting of a humidiﬁed atmosphere with
5% CO2 at 37 8C. For hormone analysis, cells were cultured
for up to 6 days and media changed every 48 h and stored at
K20 8C for analysis at a later stage. At the end of the culture
period, the cell viability was determined by neutral red dye
uptake, as described elsewhere (Campbell et al. 1998).
Immunoassays
RIA
Concentrations of androstenedione were determined from
nonextracted cell culture media using previously described
RIA methods (Campbell et al. 1998). The sensitivity of the
androstenedione assay wasw5 pg/ml andinter-and intra-assay
variation was !15%. Each experiment was repeated at least
three times with a separate pool of cells taken from different
animals (nR4 animals in each pool of cells).
The signiﬁcance of treatment effects was determined using
Student’s t-test. The data shown is representative of replicated
experiments and is presented as a percentage of the control
androstenedione production with signiﬁcance levels indicated
(**P!0.01 and ***P!0.001).
ELISA
FF concentrations of E2, activin A, activin B, and inhibin A
were measured using ELISA. Activin B concentrations were
measured using the activin B ELISA that incorporates the use
Table 1 Primer sequences used for QPCR assays and amplicon sizes.
Gene (accession) Forward primer (50–30) Reverse primer (50–30) Insert size (bp)
GAPDH (NM_001034034) GGCGTGAACCACGAGAAGTATAA AAGCAGGGATGATGTTCTGG 229
StAR (NM_001009243) GCATCCTCAAAGACCAGGAG CTTGACACTGGGGTTCCACT 194
CYP17A1 (NM_001009483) AGACATATTCCCTGCGCTGA GCAGCTTTGAATCCTGCTCT 215
3bHSD (NM_001135932) GGAGACATTCTGGATGAGCAG TCTATGGTGCTGGTGTGGA 200
CYP19A1 (NM_001123000) AATCCAGCACTCTGGAAAGC ACGTCCACATAGCCCAAGTC 152
Activin BA (NM_174363.1) GAAGAGACCCGATGTCACCCAGC TGTCGTCCTCTATCTCCACGTACCCG 113
Activin BB (NM_176852.1) ATGGCCTGGCCTCCTCCCG CTTCAGGTAGAGCCACAGGCTGGC 101
Inhibin a (NM_174094.3) GAGCCCGAGGACCAAGATGTCTCC CCTCAGCCTCTCCAGCATCTGGC 91
LHR (NM_214449) TCCGAAAGCTTCCAGATGTT GAAATCAGCGTTGTCCCATT 199
FSHR (NM_001009289) TAAGCACTTGCCAGCTGTTC CTCATCGAGTTGGGTTCCAT 196
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antibody (Ludlow et al. 2009). This assay also uses a SDS and
heat pretreatment step to remove any binding proteins that
may interfere. The FF of each individual follicle was diluted
into PBS when extracted from follicles, and this diluted sample
was added directly to the assay. The assay had a lower
detection limit of 19 pg/ml.
Inhibin A concentrations in FF were measured using a
plate modiﬁcation of a standard in-house inhibin A ELISA
as described previously with a sensitivity of 2 pg/ml and an
intra- and interplate coefﬁcients of variation !10% (McNeilly
et al. 2002). Activin A concentrations were measured using
a two-site ELISA kit that measured total activin A (Knight et al.
1996; Oxford Bio-Innovation, Oxfordshire, UK), following
the manufacturer’s instructions. This assay had a sensitivity
!78 pg/ml and inter- and intraplate coefﬁcients of variation
!10%.
An in-house ELISA was used to measure E2 in ovine FF.
Brieﬂy, 96 microwell plates were precoated with donkey
antisheep IgG (1:200; 713-005-147; Jackson ImmunoResearch,
Suffolk, UK). Plates were sealed and stored overnight at 4 8Ci n
a humidity chamber. On day 2, coating buffer was discarded
and the plate washed thoroughly with wash buffer (deionized
water C0.1% Tween-20). E2 antibody (In-house ASMR32;
1:300 000, diluted in PGBS) was added to each well and
incubated for 3 h at room temperature. The liquid was
discarded and the plate washed repeatedly. The dilution
of FF ranged from 1:2 to 1:100. The appropriate controls
and standards (7.8–1000 pg/ml; E8875, Sigma) were run in
parallel and the assay carried out in duplicate. In-house E2
tracer conjugated to HRP was diluted 1:500 in PGBS and
incubated with the sample for 2 h at room temperature
followed by washing steps. Substrate, 0.1 M citrate phosphate
buffer pH 5.0, 0.03% v/v hydrogen peroxide, and 0.1% w/v
o-phenylenediamine dihydrochloride, was added to each well.
The plate was wrapped in foil, incubated for 30 min at room
temperature, and the reaction stopped with the addition of
concentrated sulfuric acid diluted 1:10 in deionized water.
Spectrophotometry was subsequently performed at 495 nm.
The intra- and interassay CV were 6.7 and 10% respectively.
E2 values 1–30 ng/follicle were regarded as low and those
follicles were classiﬁed as nonestrogenic. Estrogenic follicles
were determined by values R30 ng/follicle.
The actual concentration of each protein measured in the FF
was calculated by accounting for the initial dilution of the FF
into 1 ml PBS when being dissected and then by using the
follicle diameter measurement an estimate of the volume of
FF contained in each follicle was calculated.
Quantitative RT-PCR
The GCs and TCs from all follicles isolated were sorted
according to the content of E2 measured from the FF collected.
The ﬁve follicles with the highest and ﬁve with the lowest levels
of E2 within each size group (1–3, 3–4, 4–6, and O6m m
diameter) for each phase of the cycle (anestrus, before LH
surge, and after LH surge) were then selected for gene
expression studies. Each follicle was treated separately, and
no pooling of RNA or FF from individual follicles was carried
out within this study.
The GCs from each individual follicle were lysed using
passive lysis buffer (PLB; Qiagen RNeasy Micro RNA extraction
kit), and each individual theca shell was transferred from
RNAlater into PLB and lysed in a tissue lyser (Qiagen). RNA
was extracted using the RNeasy Micro RNA extraction Kit, and
RNA concentration and purity (A260:A280 ratio) were measured
using a NanoDrop 1000 spectrophotometer (Thermo Fisher
Scientiﬁc, Loughborough, Leicestershire, UK). RNA was stored
at K80 8C until cDNA was synthesized from 200 ng total RNA
per reaction using Superscript VILO cDNA synthesis kit
(Invitrogen) in a 20 ml reaction.
Primer sets for expression analysis were designed to amplify
short regions of the target genes crossing an intron/exon
boundary and are described in Table 1. The primers were
prevalidated using conventional PCR and the product was
sequenced to conﬁrm authenticity. Quantitative RT-PCR was
carried out using PowerSYBR Green (Applied Biosystems,
Paisley, Renfrewshire, UK), whereby primer efﬁciency was
determined by generating standard curves. A 10 ml ﬁnal
reaction volume was prepared using 1 ml synthesized cDNA,
2! PowerSYBR Green PCR Master Mix, 5 mM primer pairs,
and nuclease-free water. The qRT-PCR cycling program
consisted of a denaturing step (95 8C for 10 min), annealing,
and extension step (95 8C for 15 s, 60 8C for 1 min) repeated 40
times, and a dissociation step (95, 60, and 95 8C for 15 s each),
using a real-time thermal cycler from Applied Biosystems (ABI-
7500). Each sample was measured in duplicate and negative
controls included a reaction using cDNA prepared leaving out
reverse transcriptase and a reaction substituting cDNA with
nuclease-free water.
The relative expression level of each target gene was
normalized to that of the housekeeping gene GAPDH for
each individual sample/follicle and was quantiﬁed using the
DDCt method.
Statistical analysis
Data are presented as average GS.E.M. and the statistical
analysis was performed using GraphPad Prism version 4.0
(GraphPad Software, Inc., San Diego, CA, USA) using an
unpaired Student’s t-test to compare the means of two groups or
ANOVA for more than two groups. P values !0.05 were
regarded as signiﬁcant, and levels of signiﬁcance are indicated
on graphs for each gene analyzed (*P!0.05, **P!0.01, and
***P!0.001).
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